← Back to Search

Implantable Device

CyPass Micro-Stent for Cataract (COMPASS XXT Trial)

N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3, month 6, month 12 (year 1), month 24 (year 2), month 36 (year 3), month 48 (year 4), month 60 (year 5), month 96 (year 8), month 108 (year 9), month 120 (year 10)
Awards & highlights

Summary

This trial looks at the long-term effects of the CyPass Micro-Stent on the cornea ten years after implantation.

Eligible Conditions
  • Cataract
  • Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3, month 6, month 12 (year 1), month 24 (year 2), month 36 (year 3), month 48 (year 4), month 60 (year 5), month 96 (year 8), month 108 (year 9), month 120 (year 10)
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3, month 6, month 12 (year 1), month 24 (year 2), month 36 (year 3), month 48 (year 4), month 60 (year 5), month 96 (year 8), month 108 (year 9), month 120 (year 10) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Annualized Percent Rate of Change in Central Endothelial Cell Density (ECD) at Each Year of Observation Reported by Mean and 95 Percent Confidence Interval
Annualized Percent Rate of Change in Central Endothelial Cell Density (ECD) at Each Year of Observation Reported by Mean and Standard Deviation
Annualized Rate of Change in Central Endothelial Cell Density (ECD) at Each Year of Observation Reported by Mean and 95 Percent Confidence Interval
+60 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cataract Surgery + CyPassExperimental Treatment2 Interventions
CyPass Micro-Stent implanted at the conclusion of cataract surgery (COMPASS trial)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cataract Surgery
2010
Completed Phase 4
~5370
CyPass Micro-Stent
2013
N/A
~2030

Find a Location

Who is running the clinical trial?

Alcon ResearchLead Sponsor
713 Previous Clinical Trials
125,770 Total Patients Enrolled
116 Trials studying Cataract
20,678 Patients Enrolled for Cataract
Clinical Operations Lead, SurgicalStudy DirectorAlcon Research, LLC
1 Previous Clinical Trials
124 Total Patients Enrolled
1 Trials studying Cataract
124 Patients Enrolled for Cataract
~12 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top